Pedro Monteiro Torres

Affiliations: 
2018- Biochemistry University of Cambridge, Cambridge, England, United Kingdom 
Google:
"Pedro Torres"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Torres P, Flores V, Flores T, et al. (2023) The salivary peptide histatin-1 enhances bone repair in vivo. Biochemical and Biophysical Research Communications. 676: 207-212
Gómez JM, Iriondo JM, Torres P. (2023) Modeling the continua in the outcomes of biotic interactions. Ecology. e3995
Quintal C, Ramos LM, Torres P. (2023) Disentangling the complexities of modelling when high social capital contributes to indicating good health. Social Science & Medicine (1982). 320: 115719
Toma R, Cai Y, Ogundijo O, et al. (2023) A clinically validated human saliva metatranscriptomic test for global systems biology studies. Biotechniques. 74: 31-44
Duque JE, Jaramillo M, López S, et al. (2023) Real-time, in situ measurement of HO generated during in situ combustion tests using 1f-normalized wavelength modulation spectroscopy with second harmonic detection. Applied Optics. 62: 108-116
Pires PGDS, Torres P, Teixeira Soratto TA, et al. (2022) Comparison of functional-oil blend and anticoccidial antibiotics effects on performance and microbiota of broiler chickens challenged by coccidiosis. Plos One. 17: e0270350
Mateluna C, Torres P, Rodriguez-Peña M, et al. (2022) Identification of VEGFR2 as the Histatin-1 receptor in endothelial cells. Biochemical Pharmacology. 115079
Mottin M, Caesar LK, Brodsky D, et al. (2022) Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins. Bioorganic Chemistry. 120: 105649
Fonollosa A, Hernandez-Rodriguez J, Cuadros C, et al. (2021) Characterizing COVID-19-related retinal vascular occlusions: a case series and review of the literature. Retina (Philadelphia, Pa.)
Job R, Qader MA, Torres P, et al. (2021) Renin-angiotensin System Blocker in COVID-19. A Single Center Study. Journal of Cardiovascular Pharmacology
See more...